低浓度阿托品治疗儿童青少年近视的应用及机制研究
Research on the Application and Mechanism of Low-Concentration Atropine in the Treatment of Myopia in Children and Adolescents
DOI: 10.12677/hjo.2025.142009, PDF,   
作者: 杨子荞：山东中医药大学眼科与视光医学院，山东 济南；冯 洁：济宁市第一人民医院眼科，山东 济宁
关键词: 阿托品；近视；角膜塑形镜；离焦眼镜；Atropine； Myopia； Orthokeratology Lenses； Defocus Glasses
摘要: 近些年，随着我国近视发生率的逐年上升，近视已经成为影响我国国民尤其是儿童青少年眼健康的重大公共卫生问题，近视防控也成为了国民关心的热点，大量研究表明阿托品在儿童近视防控方面有显著的临床意义，低浓度阿托品滴眼液是经过循证医学验证能够有效延缓近视进展的药物，联合其他近视防控手段对控制青少年和儿童近视进展有重要意义。
Abstract: In recent years, with the increasing incidence of myopia in China, myopia has become a major public health problem affecting the eye health of Chinese people, especially children and adolescents, and myopia prevention and control has also become a hot spot of national concern. A large number of studies have shown that atropine has significant clinical significance in the prevention and control of myopia in children, and low-concentration atropine eye drops are drugs that have been proven to be effective in delaying the progression of myopia, and it is of great significance to control the progression of myopia in adolescents and children in combination with other myopia prevention and control methods.
文章引用：杨子荞, 冯洁. 低浓度阿托品治疗儿童青少年近视的应用及机制研究[J]. 眼科学, 2025, 14(2): 63-68. https://doi.org/10.12677/hjo.2025.142009

参考文献

[1] 阚晶华, 席瑞洁, 王佳薇, 等. 低浓度阿托品滴眼液对青少年近视防控效果的研究进展[J]. 中国斜视与小儿眼科杂志, 2023, 31(3): 47-48.
[2] 杨宝峰, 陈建国. 药理学[M]. 第9版. 北京: 人民卫生出版社, 2018: 65-68.
[3] 王淑华, 郑海涛, 卫玉荣, 等. 阿托品抑制形觉剥夺性近视的作用机制[J]. 眼科新进展, 2002, 22(5): 331-333.
[4] 朱玉广, 刘双珍. 形觉剥夺性近视中巩膜变化的生物学机制[J]. 眼科新进展, 2003(1): 48-51.
[5] Ye, L., Li, S., Shi, Y., Yin, Y., He, J., Zhu, J., et al. (2021) Comparisons of Atropine versus Cyclopentolate Cycloplegia in Myopic Children. Clinical and Experimental Optometry, 104, 143-150. [Google Scholar] [CrossRef] [PubMed]
[6] Chua, W., Balakrishnan, V., Chan, Y., Tong, L., Ling, Y., Quah, B., et al. (2006) Atropine for the Treatment of Childhood Myopia. Ophthalmology, 113, 2285-2291. [Google Scholar] [CrossRef] [PubMed]
[7] Chia, A., Chua, W., Cheung, Y., Wong, W., Lingham, A., Fong, A., et al. (2012) Atropine for the Treatment of Childhood Myopia: Safety and Efficacy of 0.5%, 0.1%, and 0.01% Doses (Atropine for the Treatment of Myopia 2). Ophthalmology, 119, 347-354. [Google Scholar] [CrossRef] [PubMed]
[8] Yam, J.C., Jiang, Y., Tang, S.M., Law, A.K.P., Chan, J.J., Wong, E., et al. (2019) Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology, 126, 113-124. [Google Scholar] [CrossRef] [PubMed]
[9] Ha, A., Kim, S.J., Shim, S.R., Kim, Y.K. and Jung, J.H. (2022) Efficacy and Safety of 8 Atropine Concentrations for Myopia Control in Children. Ophthalmology, 129, 322-333. [Google Scholar] [CrossRef] [PubMed]
[10] Du, L., Ding, L., Chen, J., Wang, J., Yang, J., Liu, S., et al. (2024) Efficacy of Weekly Dose of 1% Atropine for Myopia Control in Chinese Children. British Journal of Ophthalmology, 109, 264-272. [Google Scholar] [CrossRef] [PubMed]
[11] 李萍, 刘婷, 孙先桃. 角膜塑形镜联合0.01%硫酸阿托品眼用凝胶对小儿近视的疗效及影响因素分析[J]. 国际眼科杂志, 2021, 21(4): 698-701.
[12] 高凡, 白雪. 角膜塑形镜联合0.01%阿托品滴眼液对青少年近视控制的疗效及安全性观察[J]. 贵州医药, 2023, 47(12): 1951-1952.
[13] Yu, S., Du, L., Ji, N., Li, B., Pang, X., li, X., et al. (2022) Combination of Orthokeratology Lens with 0.01% Atropine in Slowing Axial Elongation in Children with Myopia: A Randomized Double-Blinded Clinical Trial. BMC Ophthalmology, 22, Article No. 438. [Google Scholar] [CrossRef] [PubMed]
[14] 唐文婷, 田美, 李世贝, 等. 低浓度阿托品联合角膜塑形镜矫治近视的临床观察[J]. 国际眼科杂志, 2020, 20(6): 1044-1047.
[15] Ji, N., Niu, Y., Qin, J., Fu, A. and Cui, C. (2021) Orthokeratology Lenses versus Administration of 0.01% Atropine Eye Drops for Axial Length Elongation in Children with Myopic Anisometropia. Eye & Contact Lens: Science & Clinical Practice, 48, 45-50. [Google Scholar] [CrossRef] [PubMed]
[16] Zambrano Peralta, P., Ortiz Quito, M., Guerrero Ortiz, F. and Cervantes Anaya, L. (2023) Orthokeratology Vs. Orthokeratology Combined with Atropine for the Control of Myopia in Children: Systematic Review. Archivos de la Sociedad Española de Oftalmología (English Edition), 98, 568-576. [Google Scholar] [CrossRef] [PubMed]
[17] Guo, Y., Liu, Y., Hu, Z., Li, Y., Zhang, H. and Zhao, S. (2024) Efficacy and Safety of 0.01% Atropine Combined with Orthokeratology Lens in Delaying Juvenile Myopia: An Observational Study. Medicine, 103, e38384. [Google Scholar] [CrossRef] [PubMed]
[18] 楼辉锋, 骆丹艳, 李兴钰. 新型离焦镜片联合0.01%阿托品控制儿童近视的短期疗效观察[J]. 浙江临床医学, 2023, 25(3): 432-434.
[19] 王广勇, 王雅慧, 张金萍, 等. 多点近视离焦眼镜配合低浓度阿托品对青少年近视度数控制的研究[J]. 中国眼镜科技杂志, 2022(10): 138-140.
[20] Nucci, P., Lembo, A., Schiavetti, I., Shah, R., Edgar, D.F. and Evans, B.J.W. (2023) A Comparison of Myopia Control in European Children and Adolescents with Defocus Incorporated Multiple Segments (DIMS) Spectacles, Atropine, and Combined Dims/atropine. PLOS ONE, 18, e0281816. [Google Scholar] [CrossRef] [PubMed]
[21] 邱明忠, 邹美波, 赵晨皓, 等. 多焦点近视离焦眼镜联合阿托品滴眼液对轻中度儿童近视的治疗效果[J]. 川北医学院学报, 2024, 39(8): 1114-1117.

为你推荐